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Skeletal muscle metabolomics 
and blood biochemistry analysis 
reveal metabolic changes 
associated with dietary amino acid 
supplementation in dairy calves
Kuai Yu  1, Manolis Matzapetakis3, Daniel Valent2, Yolanda Saco1,2, André M. De Almeida4, 
Marta Terré5 & Anna Bassols  1,2
The effects of different amino acid (AA) supplementations of milk protein-based milk replacers 
in pre-ruminant calves from 3 days to 7 weeks of age were studied. Animals were divided into 4 
groups: Ctrl) Control group fed with milk protein-based milk replacer without supplementation; GP) 
supplementation with 0.1% glycine and 0.3% proline; FY) supplementation with 0.2% phenylalanine 
and 0.2% tyrosine; MKT) supplementation with 0.62% lysine, 0.22% methionine and 0.61% threonine. 
For statistical analysis, t-test was used to compare AA-supplemented animals to the Ctrl group. At week 
7, body weight and average daily gain (ADG) were measured and blood samples and skeletal muscle 
biopsies were taken. Blood biochemistry analytes related to energy metabolism were determined 
and it was shown that MKT group had higher serum creatinine and higher plasma concentration 
of three supplemented AAs as well as arginine compared with the Ctrl group. GP group had similar 
glycine/proline plasma concentration compared with the other groups while in FY group only plasma 
phenylalanine concentration was higher compared with Control. Although the AA supplementations 
in the GP and FY groups did not affect average daily gain and metabolic health profile from serum, the 
metabolome analysis from skeletal muscle biopsy revealed several differences between the GP-FY 
groups and the Ctrl-MKT groups, suggesting a metabolic adaptation especially in GP and FY groups.
Traditionally, bovine milk is considered to be the standard for feeding dairy cattle1 and before 1956, whole milk 
was the main feed for calves2. Due to the increasing demand for dairy products, many dairy cattle farms started 
feeding calves with commercial milk replacers (MRs)3. MR quality can vary according to protein source. In milk 
protein-based MR (MPMR), the protein source originates from milk protein derivatives, and they are considered 
to have the best quality as they are easier to be digested by young calves4. However, due to differences in the levels 
of certain amino acids (AAs) between MRs and bovine milk, MR AA composition may be inadequate for optimal 
calf growth, as has been described for infant formulas and human milk5,6.
Among the AAs required for pre-ruminant calf ’s growth, methionine (M), lysine (K) and threonine (T) are 
the most studied due to their low concentration in both milk and milk replacers7–10. There are indications of 
improved average daily gain (ADG) and feed efficiency intake in MPMR with MKT supplementation10 but other 
studies suggested no performance benefits comparing MPMR supplemented with methionine1, or with threonine 
and isoleucine11.
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In humans the comparison of human milk amino acid profile with that of infant formula has been used to 
propose AA supplementation or ingredient composition in infant formula5,6. The comparison of cow milk AA 
profile12 with the skimmed-milk based MR (used as a control in the present study) evidenced than some AAs 
are deficient in MR compared with cow milk. For instance, proline (P), tyrosine (Y) and phenylalanine (F) were 
7.6, 36.9, and 17.5% lower in the control MR in comparison with bovine whole milk12. Furthermore, these AAs 
may be interesting because of their role in the organism, for example proline and glycine (G) are very abun-
dant in collagen13, the main structural protein of connective tissue. Phenylalanine and tyrosine play a major 
role in the neural system as well as the hormonal regulation of metabolism as they are precursors for the syn-
thesis of catecholamines (epinephrine, norepinephrine and dopamine) and thyroid hormones13. Moreover, a 
recent study concludes that phenylalanine and tryptophan could be limiting growth in calves fed following an 
enhanced-growth feeding program14.
Even though many studies described the growth effects of AA supplementation, the effect on tissue compo-
sition has rarely been addressed, particularly from the metabolomics perspective. The hypothesis of the present 
work is that inclusion of these AAs would be able to modify the metabolome of the skeletal muscle since they 
affect growth, are important components of collagen or are precursors of anabolic or catabolic hormones. The 
metabolome, the complete set of small-molecules found within a biological sample, is directly related to the 
metabolic activity, protein activity and/or gene expression15,16. The skeletal muscle is suitable for metabolomic 
approaches, as several studies have been applied not only in differentiating meat characters of different cattle 
breeds17, geographic origins18,19, post mortem periods20 and sheep breeds and farming conditions21, but also in 
evaluating meat conservation and aging through meat exudate22.
The objective of this study is to determine the effects of a MPMR-based diet supplemented with three groups 
of amino acids (FY, GP, MKT) fed to dairy calves from 3 days up to 7 weeks of age on the ADG and blood bio-
chemical analytes. The second goal is, by using the NMR-metabolomic technology, to monitor the impact of AA 
supplementations of MPMR on the skeletal muscle metabolome, hence asserting their importance for the dairy 
industry.
Results
Performance data. Initial and biopsy time body weight and ages were measured for the four groups in the 
study, as shown in Table 1. No differences were observed between groups, although a statistical tendency for 
higher ADG was observed in MKT group compared with Ctrl (p = 0.096) and FY groups (p = 0.097).
Blood profile and multivariate analysis of data. At the end of the treatment (week 7), several serum 
biochemical analytes related to health and nutritional status as well as plasma free AA profile were determined 
(Table 2).
For serum biochemistry analytes, there were no differences between Ctrl and the GP or FY group, whereas 
MKT group presented higher values of serum creatinine compared to the Ctrl group (p = 0.023) as well as a ten-
dency for higher total protein (p = 0.059). As for the plasma AA concentration, the three supplemented AAs were 
higher in the MKT group than in the Ctrl group, as well as the concentration of plasma arginine. In the case of FY 
group, the concentration is significantly higher for phenylalanine supplemented compared with Ctrl group. In the 
case of GP, there were no significant differences compared to the Ctrl group.
Multivariate analysis of the combined data from serum biochemistry and plasma AA using PCA agreed 
with the univariate results since the different treatment groups did not show major differences (Fig. 1). Pairwise 
PLS-DA could only discriminate between the Ctrl and the MKT treatment (NC = 2, R2Y = 0.91, Q2 = 0.60). The 
VIP variables with values higher than 1.5 and therefore most responsible for the difference were, in decreasing 
VIP order, methionine, threonine, arginine, creatinine and lysine.
Muscle tissue metabolomics profile. NMR spectra analysis and compound identification. Prior to the 
metabolomics analysis of the muscle tissue extracts, the assignment of the features of the NMR spectrum to spe-
cific compounds was made. Selected spectra were assigned using database assisted spectral deconvolution with 
the Chenomx software platform using its internal database as well as the human metabolite database data (http://
www.hmdb.ca/). 2D TOCSY spectra and literature reports21,22 were also used to verify the identity of other metab-
olites. A total of 70 compounds could be successfully identified (Supplementary Table S1). From these, a subset 
of 36 metabolites was selected for quantification using Chenomx. The selection of this group was made based on 












Ctrl 44.2 ± 1.66 77.8 ± 1.73 3.3 ± 0.77 48.5 ± 1.04 740 ± 17.5
GP 47.2 ± 1.74 81.9 ± 2.46 2.4 ± 0.26 48.1 ± 0.83 759 ± 23.6
FY 42.3 ± 2.40 75.6 ± 2.58 2.6 ± 0.38 47.5 ± 0.96 740 ± 17.9
MKT 44.6 ± 2.70 80.8 ± 2.75 2.4 ± 0.65 47.6 ± 0.94 798 ± 26.9
Table 1. Performance data (Mean ± SE) in calves fed with different AA supplementations. Ctrl: Control milk 
replacer; GP: Milk replacer supplemented with glycine and proline; FY: Milk replacer supplemented with 
phenylalanine and tyrosine and MKT: Milk replacer supplemented with lysine, methionine and threonine 
(n = 8 per group). ADG = Average daily gain; BW = Body weight. Results were analysed by t-test for 
comparisons between Ctrl and treatment groups.
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section) and their relevance to the biochemical analytes of this study. The assignment of the selected metabolites 
on a representative spectrum is shown in Fig. 2.
Univariate and multivariate analyses. Upon inspection, two samples (one from GP and one from FY) were 
found to have very low concentrations. This implies a putative extraction problem and were discarded from the 
analysis. A total of 30 samples remained and were subsequently used. The mean concentrations of the 36 quan-
tified metabolites corrected for tissue mass are shown in Table 3. According to the p values from the t-test, no 
differences between Ctrl and the MKT group could be identified, whereas the GP group had higher carnosine and 
nicotinurate levels than the Ctrl group. In the FY group, a lower concentration of cadaverine and higher concen-
tration of nicotinurate were found.
Multivariate analyses of the tissue metabolite concentrations, using PCA (Fig. 3a) were consistent with the 
univariate results. As in the case of the blood profile, the different treatment groups did not show any global dif-
ferences. Pairwise PLS-DA could only discriminate between the Ctrl-FY groups (NC = 3, R2Y = 0.92, Q2 = 0.58) 
and FY-MKT groups (NC = 3, R2Y = 0.86, Q2 = 0.45). The VIP variables with values higher than 1.4 reveal that 
the most responsible for the differentiation were, in decreasing VIP order, cadaverine and nicotinurate in Ctrl - 
FY comparison and cadaverine and NAD+ in FY-MKT comparison.
Concentration
(Mean ± SE) Ctrl GP FY MKT
Serum biochemical profile
ALT (U/L) 10.4 ± 0.7 11.1 ± 1.5 9.2 ± 0.5 10.2 ± 1.2
AST (U/L) 37.5 ± 3.2 39.6 ± 5.7 33.5 ± 4.9 42.2 ± 5.9
Cholesterol (mg/dL) 64.9 ± 8.2 65.2 ± 6.5 68.0 ± 12.7 72.7 ± 6.6
Creatinine (mg/dL) 0.60 ± 0.04a 0.68 ± 0.05a 0.57 ± 0.03a 0.71 ± 0.02b
GGT (U/L) 18.5 ± 2.0 14.2 ± 1.1 16.6 ± 1.5 17.9 ± 0.6
Glucose (mg/dL) 86.3 ± 2.8 92.2 ± 4.3 96.9 ± 6.1 92.8 ± 5.4
Haptoglobin (mg/mL) 0.12 ± 0.01 0.13 ± 0.01 0.18 ± 0.06 0.16 ± 0.04
IGF-I (ng/mL) 264.4 ± 35.9 282.2 ± 31.6 245.9 ± 28.9 318.5 ± 33.3
Insulin (μg/L) 0.75 ± 0.13 1.04 ± 0.20 0.85 ± 0.11 1.07 ± 0.22
NEFAs (mM) 0.15 ± 0.03 0.16 ± 0.03 0.13 ± 0.02 0.15 ± 0.02
TGs (mg/dL) 19.91 ± 5.23 20.99 ± 4.59 16.20 ± 1.87 23.51 ± 5.37
TP (g/dL) 4.40 ± 0.11 4.42 ± 0.12 4.57 ± 0.15 4.75 ± 0.13
Urea (mg/dL) 10.54 ± 0.65 13.40 ± 1.44 9.84 ± 0.96 11.63 ± 1.07
Plasma AAs profile
Alanine (μM) 236.9 ± 16.6 228.9 ± 18.1 230.8 ± 30.8 259.6 ± 13.9
Arginine (μM) 223.7 ± 17.4a 264.2 ± 23.1a 236.7 ± 23.6a 291.9 ± 18.7b
Asparagine/Serine (μM) 177.9 ± 14.0 195.4 ± 18.9 189.2 ± 23.8 190.6 ± 10.3
Cysteine (μM) 39.0 ± 5.5 38.3 ± 5.9 38.9 ± 6.78 40.4 ± 5.9
Glutamic acid (μM) 77.8 ± 5.2 68.0 ± 6.8 65.2 ± 5.5 75.1 ± 6.5
Glycine (μM) 326.8 ± 26.1 372.1 ± 25.2 340.6 ± 19.9 368.3 ± 15.3
Histidine/Glutamine (μM) 487.1 ± 30.8 504.0 ± 34.8 485.7 ± 49.1 503.9 ± 24.6
Isoleucine (μM) 137.0 ± 11.0 130.7 ± 12.7 134.7 ± 15.8 129.56 ± 6.9
Leucine (μM) 195.20 ± 19.64 181.37 ± 21.66 188.57 ± 28.64 172.05 ± 8.31
Lysine (μM) 220.3 ± 29.6a 231.4 ± 24.3a 240.8 ± 43.4a 304.3 ± 18.8b
Methionine (μM) 36.4 ± 6.1a 35.4 ± 6.6a 36.1 ± 7.4a 73.6 ± 5.1b
Phenylalanine (μM) 56.4 ± 6.5a 57.5 ± 6.5a 79.0 ± 7.7b 52.2 ± 3.7a
Proline(μM) 137.4 ± 11.3 163.7 ± 15.0 141.3 ± 23.2 147.3 ± 10.9
Threonine (μM) 270.9 ± 10.9a 276.6 ± 24.3a 270.3 ± 25.9a 386.7 ± 26.7b
Tryptophan (μM) 49.7 ± 4.4 56.0 ± 6.3 52.2 ± 8.2 54.8 ± 3.6
Tyrosine (μM) 66.7 ± 10.3 69.6 ± 13.8 86.8 ± 8.6 67.2 ± 7.0
Valine (μM) 280.7 ± 18.7 273.4 ± 26.5 272.1 ± 35.3 267.5 ± 10.2
Table 2. Serum biochemical analytes and plasma AA concentrations in calves fed with different AA 
supplementations. Key: Ctrl: Control milk replacer; GP: Milk replacer supplemented with glycine and proline; 
FY: Milk replacer supplemented with phenylalanine and tyrosine and MKT: Milk replacer supplemented 
with lysine, methionine and threonine (n = 8 per group). ALT = alanine aminotransferase; AST = aspartate 
aminotransferase; GGT = gamma glutamyltransferase; IGF-I = insulin-like growth factor 1; NEFAs = non-
esterified fatty acids; TGs = triglycerides; TP = total protein. Results were analysed by t-test for comparisons 
between Ctrl and treatment groups. Values in a row with different superscripts are significant different 
(P < 0.05).
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Chemometric analysis. To assess if additional regions of the NMR spectra contained information that could be 
used to discriminate between the experimental groups, multivariate analysis of the full spectra (chemometric) 
was also employed. As shown in Fig. 3b, no clear separation or clustering could be observed. This is consist-
ent with the multivariate analysis based on the metabolite concentrations. However, PLS-DA could produce a 
model with acceptable statistical parameter for the comparison of the FY and Ctrl groups (NC = 3, R2Y = 1.00, 
Q2 = 0.44). A close look at the VIP data reveals that most compounds with VIP scores over 2.5 are energy-related 
metabolites, AA, AA derivatives as well as some unassigned compounds (Supplementary Table S2). After a visual 
inspection of binned spectra, an increase in the total area between 1.422–1.467 ppm and 1.632–1.760 ppm was 
identified in MKT group (Supplementary Fig. S1). According to the assignment, it was found that these regions 
mainly contain lysine/cadaverine/arginine/leucine/ornithine as well as some other unassigned metabolites.
Comparative analyses of metabolites between AA-treatments. While the focus of this work is on the differences 
between the treatments and the Ctrl group, the identification of differences among treatments has the potential 
to provide insights into the processes affected by the modifications in feed composition. Therefore, a one-way 
ANOVA with Tukey post-hoc test was used to identify the most significant changes among AA groups. The 
results of this analysis are summarized in the scheme shown in Fig. 4, where the upper portion shows the results 
for blood and the lower those for muscle tissue (complete information in Supplementary Tables S3 and S4).
Figure 1. PCA of combined serum biochemical analytes and plasma AAs. Data from dairy calves fed 
with control milk replacer (Ctrl); milk replacer supplemented with glycine and proline (GP); milk replacer 
supplemented with phenylalanine and tyrosine (FY) and milk replacer supplemented with lysine, methionine 
and threonine (MKT) (n = 8 per group). Ellipse Hotelling’s T2 (95%).
Figure 2. Representative 800 MHz 1H-NMR spectrum of calf muscle aqueous fraction. 1X zoom from 
0.0–4.8 ppm and 8X zoom from 4.8–9.4 ppm. Assignments of the 36 metabolites that were quantified: 1: 
3-Hydroxybutyrate; 2: Acetate: 3: ADP/AMP/ATP; 4: Alanine; 5: Anserine/Carnosine; 6:Betaine; 7: Cadaverine/
Lysine; 8: Carnitine; 9: Creatine/Creatine Phosphate; 10: Creatinine; 11: Fumarate; 12: Glutamine; 13: 
Glutamate; 14: Glycine; 15: Glucose/Glucose-6-Phosphate; 16: Residual H2O (not quantified); 17: Isoleucine/
Leucine/Valine; 18: Lactate; 19: Mannose; 20: Myo-Inositol; 21: NAD+/NADP+; 22: NADH/NADPH; 23: 
Nicotinurate; 24: O-Acetylcarnitine; 25: Phenylalanine; 26: Taurine; 27: Tyrosine.
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Finally, when performing a PCA analysis based on the metabolites cadaverine, carnitine, carnosine, NAD+ 
and nicotinurate, Ctrl and MKT groups tend to appear on one side while GP and FY groups on the other side 
(Fig. 5).
Discussion
The supplementation of MR with AAs is an important topic in pre-ruminant nutrition. In the present work, the 
impacts of supplementing MR with three different AA combinations (GP, FY and MKT) on weight gain, blood 
biochemistry profile and muscle metabolome were analysed after feeding the calves with control or supplemented 
MR for 7 weeks. The effectiveness of the supplementation has been evaluated by quantifying the plasma free AA 
profiles. Methionine/lysine/threonine, as well as phenylalanine, increased in the plasma of the supplemented 
groups as expected (MKT and FY, respectively). On the contrary, there were no significant differences in glycine/
proline, and in tyrosine, probably due to the non-essential character of these AA or a difference in doses or intesti-
nal absorption. An increase in plasma arginine has also been observed in the MKT group. A plausible explanation 
is that arginine and lysine share the same transport system for entering into the cell23. Thus, an increase in plasma 
lysine could compete with arginine for transport into the muscle leading to a concomitant increase in plasma 
arginine.
The profile of serum biochemical analytes considered as markers of the nutritional status of the animal (glu-
cose, urea, creatinine, cholesterol, TGs, NEFAs and total protein) did not show major differences between groups. 
Metabolites
(μMol/100 g muscle ± SE) Ctrl GP FY MKT
3-Hydroxybutyrate 0.27 ± 0.03 0.29 ± 0.04 0.35 ± 0.03 0.26 ± 0.03
Acetate 0.89 ± 0.11 0.86 ± 0.06 0.90 ± 0.05 0.83 ± 0.08
ADP+ATP+AMP 30.59 ± 3.72 33.92 ± 2.25 29.45 ± 6.25 26.93 ± 4.60
Alanine 10.88 ± 1.32 10.45 ± 1.37 10.17 ± 1.18 10.76 ± 1.06
Anserine 19.36 ± 1.68 22.72 ± 2.30 20.82 ± 2.12 18.99 ± 2.55
Aspartate 0.76 ± 0.08 0.64 ± 0.10 0.85 ± 0.10 0.78 ± 0.12
Betaine 26.61 ± 2.83 29.65 ± 2.63 27.63 ± 2.10 21.04 ± 3.81
Cadaverine 2.01 ± 0.27a 1.72 ± 0.30a 0.97 ± 0.15b 3.10 ± 0.70a
Carnitine 27.52 ± 1.62 32.75 ± 2.83 30.42 ± 1.99 24.84 ± 2.24
Carnosine 159.96 ± 7.79a 185.24 ± 8.17b 190.04 ± 14.08a 140.55 ± 15.61a
Creatine 281.90 ± 27.39 317.50 ± 24.28 293.29 ± 24.86 254.32 ± 30.07
Creatine phosphate 74.41 ± 14.75 62.08 ± 20.60 83.93 ± 17.42 65.62 ± 14.77
Creatinine 11.48 ± 2.31 10.20 ± 3.08 12.67 ± 2.02 12.21 ± 2.55
Fumarate 0.36 ± 0.08 0.45 ± 0.10 0.27 ± 0.05 0.33 ± 0.06
Glucose 11.06 ± 2.78 12.76 ± 2.37 9.20 ± 1.69 9.25 ± 1.52
Glucose-6-phosphate 12.45 ± 4.90 18.18 ± 4.40 7.52 ± 3.07 6.24 ± 1.72
Glutamate 9.54 ± 0.63 11.08 ± 1.14 9.89 ± 0.72 9.67 ± 1.58
Glycine 24.68 ± 3.23 23.46 ± 3.35 22.73 ± 3.97 22.99 ± 2.95
Isoleucine 1.05 ± 0.13 0.80 ± 0.13 1.01 ± 0.18 0.85 ± 0.08
Lactate 203.66 ± 47.73 300.35 ± 65.52 208.37 ± 61.25 169.21 ± 25.05
Leucine 1.43 ± 0.21 1.19 ± 0.20 1.39 ± 0.28 1.16 ± 0.13
Mannose 2.79 ± 0.64 3.32 ± 0.56 1.66 ± 0.41 1.76 ± 0.23
Myo-inositol 4.82 ± 0.35 4.94 ± 0.52 4.43 ± 0.32 4.56 ± 0.43
NAD+ 2.63 ± 0.12 2.88 ± 0.19 3.05 ± 0.18 1.94 ± 0.32
NADH 1.00 ± 0.17 0.69 ± 0.10 0.82 ± 0.20 0.79 ± 0.18
NADP 0.10 ± 0.01 0.12 ± 0.01 0.11 ± 0.01 0.11 ± 0.01
Nicotinurate 1.47 ± 0.08a 2.14 ± 0.22b 1.84 ± 0.07b 1.45 ± 0.15a
O-Acetylcarnitine 4.57 ± 1.38 3.64 ± 0.53 4.36 ± 0.53 2.95 ± 0.32
Phenylalanine 0.48 ± 0.05 0.42 ± 0.04 0.58 ± 0.07 0.40 ± 0.04
Pyruvate 1.20 ± 0.19 1.40 ± 0.20 1.05 ± 0.11 1.01 ± 0.09
Taurine 19.87 ± 1.34 21.94 ± 2.00 23.03 ± 1.00 18.58 ± 1.96
Tyrosine 0.72 ± 0.08 0.64 ± 0.07 0.89 ± 0.09 0.65 ± 0.08
Tryptophan 0.19 ± 0.02 0.19 ± 0.02 0.17 ± 0.02 0.19 ± 0.02
Valine 2.38 ± 0.27 1.99 ± 0.20 2.18 ± 0.33 1.85 ± 0.20
Table 3. Mean concentrations of quantified metabolites from semitendinosus muscle of calves fed with 
different AA supplementations. Key: Ctrl: Control milk replacer (n = 8); GP: Milk replacer supplemented with 
glycine and proline (n = 7); FY: Milk replacer supplemented with phenylalanine and tyrosine (n = 7) and MKT: 
Milk replacer supplemented with lysine, methionine and threonine (n = 8). Results were analysed by t-test for 
comparisons between Ctrl and treatment groups. Values in a row with different superscripts are significant 
different (P < 0.05).
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The only significant difference was observed in calves with MKT treatment, which showed higher serum values 
for creatinine versus the Ctrl group in the t-test and versus the FY group in the Tukey HSD test. These results 
suggest an increase in protein anabolism since blood creatinine concentration is positively related to muscular 
mass24. This conclusion may be reinforced by the observed tendency towards an increase in total protein in the 
MKT group versus the Ctrl group (p = 0.059). The enzymes ALT, AST and GGT were analysed for their role 
in the hepatic metabolism of AA and as markers of liver function, and no differences were observed between 
groups. Haptoglobin, marker of inflammation, and insulin and IGF-I, markers of metabolism and growth, were 
not altered either by AA supplementation.
Figure 3. PCAs of a Quantified muscle metabolites and b Chemometrics data from muscle biopsies. Data 
from dairy calves fed with control milk replacer (Ctrl, n = 8); milk replacer supplemented with glycine and 
proline (GP, n = 7); milk replacer supplemented with phenylalanine and tyrosine (FY, n = 7) and milk replacer 
supplemented with lysine, methionine and threonine (MKT, n = 8). Ellipse Hotelling’s T2 (95%).
Figure 4. Schematic overview of the differential metabolite profiles in blood (right-up corner) and muscle 
(down-left corner) between groups. Data from dairy calves fed with control milk replacer (Ctrl); milk replacer 
supplemented with glycine and proline (GP); milk replacer supplemented with phenylalanine and tyrosine 
(FY) and milk replacer supplemented with lysine, methionine and threonine (MKT). Blood analytes are shown 
in the upper-right corner, and muscle metabolites are shown in the down-left corner. Parameters at higher 
concentration in the row-group vs the column-group are presented in underlined font, whereas parameters at 
higher concentration in the column-group vs the row-group are presented in italic font. (*P < 0.05, **P < 0.01, 
no asterisk: statistical tendency 0.05 ≤ P ≤ 0.1).
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The semitendinosus muscle NMR-metabolome was then characterized. From a glimpse of the results of mus-
cle profile (Fig. 5), a remarkable finding is that the most distinguishable groups from Ctrl were FY and GP, in con-
trast with the ADG and serum analysis where MKT was the most divergent. Comparing Ctrl and MKT groups, 
there were no differences from the t-test and Tukey HSD pairwise comparisons of quantified muscle metabolites. 
Furthermore, the multivariate PLS-DAs of quantified metabolites and chemometrics results did not show an 
acceptable discrimination between Ctrl and MKT groups.
On the other hand, when comparing quantified metabolites in GP and FY groups versus Ctrl, the t-test iden-
tified nicotinurate being higher in FY and GP, carnosine being higher in GP and cadaverine being lower in FY. 
Differences between all groups are shown in Fig. 4, which summarizes the results from the ANOVA analysis with 
Tukey HSD test over the whole dataset. As explained in the figure, it is evident that GP and FY are different from 
MKT. Thus, cadaverine was lower in FY versus MKT, carnosine was higher in FY versus MKT. Nicotinurate was 
higher in GP versus Ctrl and MKT, and NAD+ was higher in GP and FY versus MKT. Furthermore, PLS-DAs of 
quantified metabolites and chemometrics shows an acceptable discrimination test between Ctrl-FY and FY-MKT 
comparison and PCA analysis based on the metabolites cadaverine, carnitine, carnosine, NAD+ and nicotinurate, 
grouped Ctrl and MKT group on one side and GP and FY groups on the other side (Fig. 5). Finally, when the sur-
roundings of the two chemical shifts of cadaverine were analysed (between 1.422–1.467 ppm and 1.632–1.760 ppm), 
an increase in the total area in MKT group was observed versus both GP and FY groups. The increased total areas 
in MKT group may due to higher concentration of lysine and/or any of these other metabolites.
In summary, the main differential muscle metabolites were cadaverine, carnosine, carnitine, nicotinurate and 
NAD+. Considering the physiological interpretation of these results, cadaverine is the product of decarboxyla-
tion of lysine. Given the fact that MKT group was supplemented with lysine, this may be the reason for higher 
cadaverine levels.
Carnosine is a dipeptide abundant in skeletal muscle of mammals25–27. Amongst other biological functions, it 
is a powerful antioxidant28,29. It is interesting to notice that the conversion of proline into hydroxyproline during 
collagen synthesis requires the action of proline hydroxylase, an enzyme that needs molecular O2 as substrate. 
Likewise, the conversion of phenylalanine into tyrosine requires oxygen as a substrate for phenylalanine hydrox-
ylase. This situation may indicate that the muscle cell in the groups supplemented with GP or FY could be under 
a situation of oxidative damage. The increase in carnosine concentration could alleviate this condition.
Carnitine is involved in the transport of acyl groups to the mitochondria, and thus in oxidative metabolism. 
This metabolite was also increased in GP. Similarly, nicotinurate, one of the metabolites of NAD+, is increased 
in the GP versus Ctrl and MKT groups. NAD+ is the final product of the oxidative respiratory chain and it has 
increased concentrations in both GP and FY groups.
Altogether, these results suggest a higher importance of aerobic metabolism in GP and FY groups.
Despite the fact that this study reveals the metabolomic changes due to the AA supplementation adaptation, 
two main limitations need however to be addressed. Firstly, this study is only focused on muscle metabolome, thus 
the general metabolomic profile is not presented. These results may be extended by analyzing the urine and/or 
serum metabolome. Secondly, only the aqueous fraction was analysed in the NMR. As such, organic phase 
remained unstudied. As a result, the lipid metabolism is not included and may omit some important information. 
Addressing these two points are important follow-up studies.
Figure 5. PCA based on 5 quantified muscle metabolites (cadaverine, carnitine, carnosine, NAD+ and 
nicotinurate). Data from dairy calves fed with control milk replacer (Ctrl, n = 8); milk replacer supplemented 
with glycine and proline (GP, n = 7); milk replacer supplemented with phenylalanine and tyrosine (FY, n = 7) 
and milk replacer supplemented with lysine, methionine and threonine (MKT, n = 8). Ellipse Hotelling’s T2 
(95%).
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Conclusions
To the best of our knowledge, this work is the first to report a NMR metabolomics study of skeletal muscle of 
calves with diets differing in AA supplementation. Herein we conclude that the AA supplementation added to the 
MR in the conditions given in the present work does not have a marked influence in the ADG in calves from 3 
days to 7 weeks of age. Nevertheless, calves supplemented with MKT had higher serum creatinine concentration, 
considered an indicator of increased muscular mass. These differences between MKT and the Ctrl group are 
however not reflected in the metabolomics analysis of skeletal muscle, as all profiles are very similar. Nevertheless, 
the metabolomic analysis of skeletal muscle revealed several differences between the GP/FY groups and the Ctrl/
MKT groups, suggesting a metabolic adaptation especially in the GP ad FY groups. In conclusion, our results sup-
port the performance improvement after MKT supplementation in MR compared with Ctrl and GP and FY com-
binations, and reveal that different AA profile of calf MR can modify protein and muscle metabolism. This study 
may help the dairy industry to take metabolic factors into account when supplementing relevant AAs in MR.
Methods
Animals and housing. Animals were managed according to the recommendations of the Animal Care 
Committee of Institut de Recerca i Tecnologia Agroalimentàries (IRTA) under the approval research protocol FUE-
2017-00587321, authorization code 9733. Thirty-two Holstein male calves (weighing 44.6 ± 1.07 kg of BW at the 
age of 2.7 ± 0.27 days) were obtained from Granja Murucuc (Gurb, Barcelona, Spain) and housed individually 
at IRTA Torre Marimon (Caldes de Montbui, Barcelona, Spain). Animals used in the component here described 
were a part of a larger study with a higher number of animals that aimed to evaluate calf performance. The sample 
size was chosen based on the previous similar studies18,19,21,30–32.
Diet treatments and performance recordings. MR was offered in 3-L nipple bottles twice a day, and all 
animals followed the same MR feeding program. Calves were fed on 4 L/d commercial milk replacer at 12.5% Dry 
Matter (DM). Milk replacer (Nukamel, Weert, The Netherlands) contained 25.4% CP (based on skimmed milk 
protein, and whey protein concentrate) and 20.3% fat from experimental days 1 to 4. Subsequently, the volume 
of MR was increased to 5 L/d from day 5 to 7, followed by 6 L/d from days 8 to 14, and 6 L/d at 15% DM concen-
tration from day 15 to 49. At day 50, MR was reduced to one feeding per day of 3 L at 15% DM until day 56 when 
animals were fully weaned.
Calves were divided in four different treatments according to AA supplementation in the MR formula 
(which replaced whey protein concentrate in the control MR). All AAs were provided by Livzon Group (Fuxing 
Pharmaceutical, Ningxia (China)). Treatments were previously defined in a list, which indicated the MR treat-
ment in each individual calf box. Then, as calves were arriving to the facilities, they were allocated correlatively 
to the individual boxes with a predetermined treatment. In this way, the only identification of the calves was 
the eartag number, which allowed the blinding of researchers and care-takers to treatment allocation. The four 
treatments were:
A (Ctrl): Control group with no AA supplementation
B (GP): supplementation with 0.1% glycine plus 0.3% proline in the MR formula
C (FY): supplementation with 0.2% phenylalanine plus 0.2% tyrosine in the MR formula
D (MKT): supplementation with 0.62% lysine plus 0.22% methionine plus 0.61% threonine in the MR formula
Ingredients and chemical composition are shown in Table 4. All animals had free access to water, and a pel-
leted concentrate starter feed (Pinallet, Cardona, Spain) was limited to minimize the impact of concentrate feed-
ing on amino acid absorption: 100 g/day from day 1 to day 17 of study, 200 g/d from days 18 to 21, 300 g/d from 
day 22 to day 24. Subsequently, 400 g/d were used from day 25 to day 28, 500 g/d, from day 29 to day 31, 600 g/d 
from day 32 to day 33 d, 700 g/d at day 34, 800 g/d at day 35, 1,000 g/d from day 36 to day 42, 1,200 g/d from day 43 
to day 49, and ad libitum afterwards until 63 d of study, when the study finished. Information about composition 
and AA concentration in the starter is provided in Table 5. Chopped barley straw was offered ad libitum during 
this study (Table 6). Calves were weighed weekly with an electronic scale (Mobba SC-01, Badalona, Spain) until 
the end of the study.
Blood and muscle sample collection. At the 7th week of the study, blood samples were obtained from 
jugular vein 2 h after the morning MR feeding, and were kept in 10 ml Vacutainer tubes without anticoagulant to 
obtain the serum for biochemistry profiles or with lithium heparin for plasma AA analyses. Serum and plasma 
were obtained by centrifugation at 1,500 g for 10 min and stored in aliquots at −20 °C until further analysis.
At 47.9 ± 0.46 days of age, a biopsy was obtained from semitendinosus muscle. Briefly, animals were injected 
with xylazine intravenously at the dose of 0.005 mL/kg BW, once the animals were sedated, the hind leg was 
shaved and disinfected with iodine povidone. Then, 2 mL of 0.02 g/mL lidocaine were subcutaneously injected as 
a local anaesthetic. A 3-cm cut in the skin and subcutaneous layer was done with a scalpel, and a 2-cm zone of the 
muscle was delimited with suture, and it was dissected with curve scissors. Finally, the muscular, subcutaneous 
and cutaneous layers were sutured. Muscle samples were immediately frozen into liquid nitrogen and subse-
quently kept at −80 °C until further analysis.
Quantification of plasma AAs. Plasma AAs were measured by HPLC following a modified protocol33. At 
the day of assay, 100 µl of thawed plasma were transferred to a 2.0 mL micro-centrifuge tube and 10 µl of 10 mM 
DTT in PBS (pH 7.4) and 5,79 µl 2.5 mM GABA as internal standard were added. The solution was vortexed for 
30 s and an equivalent volume of 10% sulfosalicylic acid was added to precipitate the proteins, followed by mixing 
for 2 min. The samples were centrifuged at 14,000 g for 10 min at 4 °C and the supernatant collected34.
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For derivatization, the AccQ Fluor (Waters, Milford, MA, USA) method was used following the instructions 
provided by the manufacturer. A total of 10 μL standard solution or supernatant of deproteinized plasma sample 
was taken into a 1.5 mL micro-centrifuge tube, buffered with 70 µL Waters AccQFluor Borate Buffer and derivat-
ized by addition of 20 µL of AccQ-Fluor reagent, vortexed and heated for 10 min at 55 °C.
Ingredients
(g/kg DM) Ctrl GP FY MKT
Whey protein concentrate 35a 150 150 157 156
Skimmed milk powder 390 400 400 400
Fatted whey 50b 390 390 388.5 390
Whey protein concentrate 60c 40 26 20.5 9.5
Premixd 30 30 30 30
Proline 0 3 0 0
Glycine 0 1 0 0
Phenylalanine 0 0 2 0
Tyrosine 0 0 2 0
Lysine 0 0 0 6.2
Methionine 0 0 0 2.2
Threonine 0 0 0 6.1
Composition, (g/kg DM, unless otherwise stated)
DM (g/kg) 979 974 981 980
CP 254 255 251 254
EE 202 204 202 202
Lactose 448 454 456 444
Ashes 70 73 70 69
Table 4. Ingredients and chemical compositions of milk replacers. Key: Ctrl: Control milk replacer; GP: Milk 
replacer supplemented with glycine and proline; FY: Milk replacer supplemented with phenylalanine and tyrosine 
and MKT: Milk replacer supplemented with lysine, methionine and threonine. CP = crude protein; DM = dry 
matter; EE = ether extract. aContains 35% protein in the whey. bContains 50% protein in the whey. cContains 
60% protein in the whey. dMineral and vitamin composition: Vitamin A 25,000 IU/kg; Vitamin D3 4,500 IU/kg; 
Vitamin E 300 mg/kg, Vitamin C 300 mg/kg, Vitamin B1 16 mg/kg, Vitamin B2 10 mg/kg, Vitamin B6 10 mg/kg, 
Vitamin B12 80 mg/T, Vitamin K 5.5 mg/kg, Folic acid 1 mg/kg, Pantothenic acid 23 mg/kg, Niacin 50 mg/kg, Fe 
150 mg/kg, Zinc 170 mg/kg, Copper 10 mg/kg, Manganese 40 mg/kg, Iodine 1.3 mg/kg, Selenium 0.4 mg/kg.
Composition
DM (%) 87.55
CP (% DM) 17.85



















Table 5. Chemical omposition and aminoacid content in the starter feed. CP = crude protein; DM = dry 
matter.
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HPLC was performed on an Elite LaCHrom (Hitachi, Tokyo, Japan) equipped with an UV detector (Hitachi 
L-24200, Tokyo, Japan) with a Novapak C18 column (300 mm × 3.9 mm) from Waters. The flow rate was 1.0 ml/min 
and the column temperature was kept at 28 °C. The injection volume was 10 μL and the detection wavelength 
was set at 254 nm. The solvent system consisted of two eluents: (A) AccQ > Tag eluent A concentrate (10%, v/v) 
and water (90%, v/v) and (B) 60% acetonitrile/40% water. The following gradient elution was used: 0 to 0.50 min, 
100% A; 0.5 min, 98% A to 2% B; 20 min, 93% A to 7% B; 32 min, 91.5% A to 8.5% B; 40 min, 82% A to 18% B; 
47.5 min: 79% A to 21% B; 55 min: 60% A to 40% B; 60 min: 100% B. Pure AAs were used as standards and GABA 
was used as internal control (Sigma, St. Louis, MO, USA). Standards were prepared at 2.5 mM stock solutions in 
0.1 M HCl and was serially diluted from 500 µM to 7.81 µM to perform the standard curve in order to quantify AA 
of plasma samples. EZChrom Elite system V3.1.7 software (Agilent, Santa Clara, CA, USA) was used for system 
control and data acquisition. Validation of the technique showed a good precision (Coefficients of Variation from 
1% to 5% for all AA), good linearity (R2 > 0.998) except for serine (R2 = 0.990) and cysteine (R2 = 0.989) and a 
limit of quantification lower than 10 μM (except for serine (11 μM) and histidine/glutamine (21 μM).
Determination of serum biochemical analytes. Serum biochemistry analytes were analysed with the 
Olympus AU400 analyser with following techniques and OSR reagents (Olympus System Reagent)35,36: glucose 
(HK method), urea (GLDH method), creatinine (Jaffé method), cholesterol (CHOP-PAP-method), triglycer-
ide (GPO-PAP method), total protein (Biuret method), ALT (International Federation of Clinical Chemistry 
(IFCC) method), AST (IFCC method) and GGT (IFCC method). NEFAs were determined with NEFA-C reagent 
(Wako Chemicals GmbH, Neuss, Germany). Quality control protocols were based on the daily quantification 
of two control sera of low and high concentration (Control serum I and Control serum II, Beckman Coulter) 
Haptoglobin was determined by a colorimetric method (Tridelta, Ireland). Insulin and IGF-I were determined by 
ELISA (Bovine Insulin ELISA from Mercodia, Uppsala, Sweden and Human IGF-I ELISA E20 from Mediagnost, 
Reutlingen, Germany). This reagent is suitable for bovine samples, as declared by the manufacturer, but the 
cross-reactivity was not assessed by the authors.
Intra-assay Coefficients of Variation (CV) were: glucose (1.7%), urea (2.1%), creatinine (1.4%), choles-
terol (1.1%), triglycerides (3.0%), total protein (0.9), ALT (1.7%), AST (1.0%), GGT (0.6%), NEFAs (2.7%), 
Haptoglobin (4.1%), insulin (4.1%) and IGF-1 (4.4%).
Muscle extraction and NMR data acquisition. Muscle tissues were transferred from −80 °C freezer to 
dry ice. All muscle tissues were ground into fine powder while mixed with liquid nitrogen in a mortar and pestle. 
The extraction of the aqueous metabolites was performed using a modified chloroform/methanol method previ-
ously described21. In brief: approximately 0.5 g of muscle tissue was mixed with 1.2 mL of chloroform/methanol 
(1:2 v/v) in a glass tube and was vortexed for 1 min. Then an extra 0.4 mL of chloroform was added to compensate 
the evaporated chloroform and the tube was vortexed for an additional 1 minute. Afterwards 0.4 mL of double 
distilled water was added and the tube vortexed again for 1 min. The homogenate was centrifuged at 1935 g for 
20 min at 4 °C. 1000 μL of the top (methanol/water) fraction was transferred into a 2 mL polypropylene tube and 
dried in a centrifugal vacuum concentrator. To resuspend the dried sample for NMR analysis, 600 µL of phosphate 
buffer in D2O (150 mM; pH 6.6 (pD 7.0); with 100 μM of TSP-D4 (deuterated Trimethylsilylpropanoic acid)) were 
added, followed by 1 min vortexing and 10 min centrifugation at 14,100 g at room temperature. The supernatants 
were transferred into NMR borosilicate tubes rated for 800 MHz (New Era, Vineland, NJ, USA).
1D 1H NOESY spectra were collected on an 800 MHz NMR spectrometer equipped with a room temperature 
HCN inverse Z-gradient probe (Bruker Biospin, Billerica, MA, USA). The pulse sequence used for 1D gradient 
NOESY with water pre-saturation was “noesygppr1D” with the Bruker standard acquisition parameters for pro-
filing (spectral width: 16393.443 Hz, recycling delay: 4 s, acquisition time: 1.9988480 s, mixing time 10 ms). 96 
scans and 8 dummy scans were used for each spectrum resulting in a 10-min experiment. For select samples, 
additional homonuclear and heteronuclear spectra (1H J-resolved, 1H-1H COSY, and 1H-13C HSQC) spectra were 
also collected to assist with compound identification.
NMR data processing and analysis. Spectra were processed with 1 Hz exponential appodization, 
no additional zero filling and polynomial baseline correction with the TopSpin 3.2 software (Bruker Biospin, 
Billerica, MA, USA). Compound quantification in reference to the TSP internal standard was performed with the 
Chenomx 8.1 NMR Suit (Edmonton, Alberta, Canada). The limit used for compound quantification in Chenomx 
was set at 0.002 mM.
Composition
DM (%) 83.8
CP (% DM) 3.8
ADF (% DM) 52.9
NDF (% DM) 79.7
Ash content (% DM) 6.4
Table 6. Chemical composition of the barley chopped straw. CP = crude protein; DM = dry matter; 
ADF = Acid Detergent Fibre; NDF = Neutral Detergent Fibre.
www.nature.com/scientificreports/
1 1ScIeNTIFIc RepoRTS |  (2018) 8:13850  | DOI:10.1038/s41598-018-32241-4
Metabolomics data have been deposited to the EMBL-EBI MetaboLights database (DOI: 10.1093/nar/
gks1004. PubMed PMID: 23109552) with the identifier MTBLS720. The complete dataset can be accessed here 
https://www.ebi.ac.uk/metabolights/MTBLS720.
Statistical analysis. Performance and blood data. The univariate analysis was carried out with the SPSS 
24 (IBM, Armonk, NY, USA). The significance level was declared at P < 0.05 and a tendency was considered at 
0.05 ≤ P ≤ 0.1. Descriptive data are presented with the means and the standard error (mean ± SE). Shapiro-Wilks 
test was used to assess normality of data. Means were compared to the Ctrl group by a t-test and for pairwise com-
parisons, ANOVA with Tukey HSD post hoc was applied. The multivariate analyses were performed by SIMCA 
13.0.3 (Umetrics AB, Umeå, Sweden) after applying auto-transform to reduce data skewness and UV scaling to 
reduce relative importance of large values.
Muscle data. For Chemometric statistical analysis, processed spectra were loaded into “R” where peak align-
ment was performed with SPEAQ. The data were then exported into a coma-separated value (CSV) file and 
loaded into SIMCA 13.0.3. All spectra were treated with a log transform and by Pareto scaling. For the whole 
groups, unsupervised Principal Components Analysis (PCA) was performed to detect outliers, patterns and 
trends. For pairwise Partial Least Square Discriminant Analyses (PLS-DAs), Q2 > 0.4 were selected as acceptable 
models and Variable Importance in Projection (VIP) scores were used to identify metabolites responsible for the 
separation. These metabolites together with others that are relevant for the project were then quantified using 
database assisted spectral deconvolution that was performed using Chenomx. The resulting concentration were 
normalized based on the mass tissue used for extraction and then further performed univariate analysis by SPSS 
24 and multivariate analysis by SIMCA 13.0.3 after applying auto-transform and UV scaling.
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